Chamber and committees

The list of private providers is owned by the UK Government. All providers included on the list must complete or be working towards full United Kingdom Accreditation Service accreditation. If a provider does not complete this or fails the accreditation then they are removed from the list.

Officials continue to work with UK Government to monitor performance of private tests providers. This is done at the private testing provider working group with the Department of Health and Social Care and the devolved administrations, which meet every 2 weeks.

The providers have various standards to meet, which are defined in our regulations and the key performance indicators (KPIs) that are set on turnaround times, customer service and sequencing requirements. Any provider not achieving these standards or engaging in unethical practices are removed from the list.

If individuals are having or have had an issue with a private test provider, they should first report this back to the provider. If they are not satisfied with this then they can submit a complaint here: https://enquiries.test-and-trace.nhs.uk/s/enquiries where the complaint will be investigated.

The amount spent on executive search, advertising and assessment centre costs for the Director General Net Zero role is £26,837. Three candidates were shortlisted and assessed. Two candidates were interviewed by the final panel.

The Scottish Government’s commitment to the early diagnosis of cancer is reflected in the £44m Detect Cancer Early (DCE) Programme. The NHS Recovery Plan – published August 2021 – commits an additional £20m for the DCE Programme, to provide greater public awareness of signs and symptoms of cancer and supporting the development of optimal cancer pathways to improve earlier diagnosis rates. Research will be undertaken in the coming months to better understand the possible barriers and levers to early diagnosis that any new DCE campaigns should focus on.

An overarching DCE social marketing campaign 'Survivors' was previously developed in close consultation with the Scottish Cancer Coalition in 2018. The campaign aimed to reduce fear around cancer and empower people to take early action, be it visiting their GP practice or attending screening when invited. To coincide with the campaign, a symptom-checker tool was developed on DCE’s website (getcheckedearly.org) to raise awareness of the early signs and symptoms of cancer, including blood cancer.

There are no plans to introduce protected learning time at present. It is a decision for employers to allow staff time to study for additional qualifications.

To support delivery of the Community Pharmacy First Plus service, Community Pharmacist contractors receive backfill (up to £5750) to release community pharmacists to undertake their IP qualification (5 days face to face teaching + 12 days Period of Learning in Practice), clinical skills training (4 days) and also access to a maximum of 3 sessions at a CCC Teach and Treat Training Hub (backfill up to £750).

Transport Scotland has undertaken to evaluate the Young Persons’ Free Bus Travel Scheme following the first full year of operation. The evaluation will assess the short, medium and long term impact of the scheme by comparing conditions at different stages.

Baseline data collection is under way, including an online survey with children, young people and parents, secondary data collection, and assessment of travel behaviour, attitudes and perceptions of travel prior to the scheme’s starting on 31 January 2022.

During the first year of operation, short term outcomes such as uptake of entitlement and travel behaviour will be evaluated. This will be followed by a more thorough evaluation following the first full year of operation which will assess medium and long term outcomes such as changing travel behaviour and improving access to education, training and employment.

Further evaluations are planned to take place periodically to ensure that the scheme is meeting its stated objectives and offers public value.

The Scottish Government funds Energy Saving Trust (EST) to deliver the EST E-bike Grant Fund. Grants provided to local authorities since 2018 are presented in the following table:

We are working with owners and representatives to fund the Single Building Assessments in the pilot phase. All £97.1m received in consequentials will be spent on assessments and cladding remediation over the lifetime of the programme.

Because of the unpredictable lifecycle of this particular organism, it is not possible to routinely test buildings for an Aspergillus infection. Where water ingress creates the conditions for mould, NHS Greater Glasgow and Clyde’s staff work to remedy faults as soon as they are found and remove any mould with oversight from Infection Prevention and Control (IPC). Patients with Aspergillus are visited by an infection prevention and control nurse. Advice on the correct antibiotics to administer to patients is given by a Microbiology/ICD/antimicrobial pharmacist on request of the clinical teams.

A variety of risk assessments are undertaken across all wards in the Hospital, including 4a and 4b, covering social distancing, hand hygiene, infection control precautions (SICPs) audits every 6 months, patient placement, and the verification of the specialist ventilation systems in ward 4b. The new and innovative Infection Prevention and Control (IPC) dashboard available to all staff enables real time review of IPC data, and allows for a quick and effective response to any risks reported.

The under 26’s review has been undertaken during a period of time where there has been considerable changes in the policy landscape within which concessionary travel rests, and there currently remains a level of uncertainty as the long term impacts of COVID-19 on public transport are not yet known.

During the review process a commitment was made to introduce free bus travel to under 19s, which was then extended to under 22s which is due to be introduced on 31 January 2022. The impact of the under 22s scheme will provide useful real-world evidence for examining further cost-benefit analysis and determining the value of any future extensions of free bus travel (or other modes) for targeted age ranges or groups of society.

The under 26’s review is being finalised for publication and will be published following the introduction of the under 22s scheme.